Commutity acquired pneumonia scores utility. PSI (FINE) vs BTSm (CURB)

I. Aldabo, C. Esquinas, M. Valencia, J. R. Badia, P. Dambrava, G. Penarroja, J. Mensa, A. Torres (Barcelona, Spain)

Source: Annual Congress 2005 - Assessment and intervention from primary care centre to hospital
Session: Assessment and intervention from primary care centre to hospital
Session type: Oral Presentation
Number: 261
Disease area: Respiratory infections

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Aldabo, C. Esquinas, M. Valencia, J. R. Badia, P. Dambrava, G. Penarroja, J. Mensa, A. Torres (Barcelona, Spain). Commutity acquired pneumonia scores utility. PSI (FINE) vs BTSm (CURB). Eur Respir J 2005; 26: Suppl. 49, 261

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Site of care for community-acquired pneumonia (CAP) patients with CRB-65 score of 0-1 and pneumonia severity index (PSI) risk class (RC) of IV-V: what to do when this discrepancy occurs. Results from the CAPO international study
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008


Comparison of PSI, A-DROP, CURB-65, CRB-65, and SOAR indices in hospitalized patients with community acquired pneumonia
Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Year: 2012

Prognostic value of the pneumonia severity index (PSI), CURB-65 for young and elderly patients
Source: Annual Congress 2009 - Pulmonary infections
Year: 2009


Which one is superior in predicting 30 and 90 days mortality after COPD exacerbation: DECAF, CURB-65, PSI, DOSE, BAP-65
Source: Virtual Congress 2020 – Monitoring of patients with COPD
Year: 2020


Does the use of the CURB-65 score improve outcomes in community-acquired pneumonia (CAP)?
Source: Annual Congress 2009 - Pulmonary infections
Year: 2009


Performance of CURB-65 and CURB-age in community acquired pneumonia (CAP)
Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers
Year: 2009


Physicians should not use the pneumonia severity index (PSI) or CRB-65 in deciding the need for hospitalization in cancer patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2007; 30: Suppl. 51, 41s
Year: 2007

The pneumonia severity index (PSI) do not underestimate the severity of community-acquired pneumonia (CAP) in young patients: results from the CAPO international study
Source: Annual Congress 2008 - Factors related to outcome of community-acquired pneumonia
Year: 2008


Role of procalcitonin (PCT) as a marker of severity of community acquired bacterial pneumonia (CABP) compared to PSI, CRB65 abd CURB65
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013


A prospective study of the relationship of severity assessed by modified CURB-65 score and mortality in patients with commmunity acquired pneumonia (CAP)
Source: Eur Respir J 2006; 28: Suppl. 50, 374s
Year: 2006

Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes
Source: Eur Respir J 2008; 31: 349-355
Year: 2008



Surfactant protein D (SPD) like marker of effectiveness ofphosphatidylcholine treatment outcomes in patients (pts) with community acquired pneumonia (CAP)
Source: International Congress 2015 – Healthcare organisation and appropriateness in lung disorders
Year: 2015


Reasons that justify hospitalization for community-acquired pneumonia (CAP) patients with CURB-65 score 0-1
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008


I-ROAD could be efficient in predicting severity of community acquired pneumonia (CAP) or healthcare-associated-pneumonia(HCAP)
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010

Community acquired pneumonia (CAP) and PSI mortality risk stratification
Source: Eur Respir J 2004; 24: Suppl. 48, 413s
Year: 2004

Validation of a computer predictive model to stratify risk and site of care in community acquired pneumonia (CAP)
Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches
Year: 2005


Definition of severity and the reasons for hospitalization (RH) in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2005; 26: Suppl. 49, 641s
Year: 2005

Prevalence of hyponatremia (HN) in children with community acquired pneumonia (CAP) and its relation to disease severity, outcomes
Source: Virtual Congress 2021 – Acute paediatric respiratory infections
Year: 2021


Predictive validity of SF-36 general health (GH) scale for COPD exacerbation
Source: Annual Congress 2005 - Assessment and intervention from primary care centre to hospital
Year: 2005


Is severity index enough to assess hospital admission of community-acquired pneumonia (CAP) patients?
Source: Annual Congress 2006 - Evaluation of risk factors in community-acquired pneumonia
Year: 2006